Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the Optogenetics Market Grow Over the Forecast Period Based on Its Expected CAGR?

The rapid expansion of the optogenetics market has been noticeable in recent years. It is projected that the market value will increase from $35.91 billion in 2024 to $41.16 billion in 2025, indicating a compound annual growth rate (CAGR) of 14.6%. The historical period’s growth is primarily attributed to an increase in neurological disorders, heightened funding in life sciences, progression in drug discovery and development, advancements in mapping neural circuits, the application of optogenetics in drug screening, and progress in neurophotonics.

The size of the optogenetics market is predicted to undergo fast expansion in the upcoming years, reaching $71.95 billion by 2029, at a compound annual growth rate (CAGR) of 15.0%. The increase during this forecast period can be attributed to factors such as its use in therapeutic applications, clinical trials, translation, its expansion into non-neuronal cells, its application in brain-machine interfaces, and the creation of novel light-sensitive proteins. Key trends during this forecast period involve progress in optogenetic tools and technologies, partnerships with pharmaceutical firms, the application of optogenetics in drug discovery and development, expansion into non-neural cell types, and convergence with other imaging technologies.

What Are the Primary Drivers Supporting the Growth of the optogenetics Market?

As the incidence of Parkinson’s disease and epilepsy continues to escalate worldwide, the optogenetics market is anticipated to experience corresponding growth. Parkinson’s disease is a brain degenerative condition marked by motor symptoms such as slowed movements, tremors, stiffness, balance issues, and is often accompanied by cognitive impairment, mental health concerns, sleep problems, pain, and sensory disturbances. Epilepsy is another neurological condition characterized by seizures. Optogenetic therapy uses light-responsive proteins to treat Parkinson’s disease, which can be engineered using gene therapy techniques to activate or deactivate in the presence of specific light types, leading to the restoration of normal brain function in Parkinson’s disease patients. For example, as claimed by The Parkinson’s Foundation, a US organization committed to enhancing the quality of life of individuals living with Parkinson’s disease, there was a significant surge in the annual Parkinson’s disease diagnoses in December 2022, close to 90,000, which is a considerable increase from the earlier estimation of 60,000. Further, the count of individuals dealing with PD in the U.S. is projected to climb to 1.2 million by 2030 from 930,000 in 2020. Consequently, the global uptick in Parkinson’s disease and epilepsy incidence is set to fuel the expansion of the optogenetics market.

Explore Comprehensive Insights Into The Global Optogenetics Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9009&type=smp

Who Are the Dominant Players Expanding Their Reach in the Optogenetics Market?

Major companies operating in the optogenetics market include:

• Elliot Scientific Ltd._x000D_

• Shanghai Laser & Optics Century Co. Ltd._x000D_

• GenSight Biologics_x000D_

• Danaher Corporation_x000D_

• Coherent Inc._x000D_

What Are the Top Trends Shaping the Evolution of the Optogenetics Market?

In the optogenetics market, the principal emerging trend is the creation of cutting-edge systems. Major players in the optogenetics industry are investing in the development of cutting-edge optogenetics systems and tools to secure their market presence. To illustrate, in June 2022, Bruker Corporation, a leading optogenetics tool supplier based in the US, unveiled the NeuraLight 3D Ultra. This enhanced 3D holographic stimulator for optogenetics modules was designed to aid advanced neuroscience and optogenetics research on Bruker’s Ultima 2Pplus Multiphoton Microscope. The NeuraLight 3D Ultra provides state-of-the-art 3D holographic photostimulation customized for comprehensive functional research on neural networks and brain computation.

Secure Your Global Optogenetics Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/optogenetics-global-market-report

What Are the Core Segments of the Optogenetics Market, and How Do They Contribute to Growth?

The optogenetics market covered in this report is segmented –

1) By Product: Lasers, Actuators, Sensors

2) By Application: Neuroscience, Behavioral Tracking, Retinal Disease Treatment, Other Applications

3) By End User: Hospitals And Clinics, Diagnostics Centers, Research Centers, Other End Users

Subsegments:

1) By Lasers: Continuous Wave Lasers, Pulsed Lasers, Fiber-Coupled Lasers

2) By Actuators: Channelrhodopsins, Halorhodopsins, Opto-xRs

3) By Sensors: Calcium Sensors, Voltage Sensors, Genetically Encoded Indicators

Which Regions Are Setting the Pace for Optogenetics Market Growth?

North America was the largest region in the optogenetics market in 2024. The regions covered in the optogenetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

How Is the Optogenetics Market Defined Across Different Regions?

Optogenetics is a comprehensive technique that uses optical systems and genetic engineering technologies to accurately regulate and monitor the biological processes of a cell, group of cells, tissues, or organ with high temporal and spatial resolution. Optogenetics is to monitor and control the physiological activity of neurons and other cell types that include light sensors frequently employed to identify the underlying causes of ailments such as Parkinson’s, memory illnesses, anxiety, addiction issues, mood swings, and other conditions.

Browse Through More Similar Reports By The Business Research Company:

Enzymes Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/enzyme-global-market-report

NGS-Based RNA-Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Tumor Embolization Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: